Form 4: SOPHiA GENETICS SA Executive Sells Shares
Insider Transaction (Form 4)
Kevin Puylaert, Chief Sales Officer of SOPHiA GENETICS SA, sold 216 shares of common stock on October 5, 2026.
Summary
- Open-market sale: disposed of 185 Ordinary Shares at $8.06 ($1,491) on October 5, 2026; holds 147,763 after (Direct).
- Open-market sale: disposed of 31 Ordinary Shares at $7.92 ($246) on October 5, 2026; holds 147,732 after (Direct).
Sentiment
Score: 4
Explanation: StockSavvy.ai views this as a mildly negative signal: an insider sold $1,737 of stock on the open market.
Insider Transactions
Kevin Puylaert — Officer (Chief Sales Officer)
| Date | Transaction | Security | Shares | Price | Value | Held After |
|---|---|---|---|---|---|---|
| 2026-10-05 | Open-market sale | Ordinary Shares | 185 | $8 | $1.5K | 147,763 |
| 2026-10-05 | Open-market sale | Ordinary Shares | 31 | $8 | $246 | 147,732 |
Key Dates
| Date | Description |
|---|---|
| 2026-10-05 | Open-market sale (185 shares) |
| 2026-10-05 | Open-market sale (31 shares) |
Keywords
insider transaction, Form 4, SOPH, SOPHiA GENETICS SA, bearish, Kevin Puylaert
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.